These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 10522809

  • 1. Pathogenic and clinical aspects of Graves' disease.
    Feldt-Rasmussen U, Rasmussen AK, Zimmermann-Belsing T, Hartoft-Nielsen ML.
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S71-4. PubMed ID: 10522809
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Medical aspects on surgery in Graves' disease. Clinical review.
    Karlsson FA, Winsa B, Rastad J, Johansson H.
    Acta Chir Scand; 1990 Jan; 156(1):47-51. PubMed ID: 1690941
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. What can the European Multicenter Trial on the treatment of Graves' disease with antithyroid drugs teach us about the course of thyroid-associated orbitopathy (TAO)? European Multicenter Trial Group.
    Benker G, Kahaly GJ, Reinwein D.
    Exp Clin Endocrinol Diabetes; 1999 Jan; 107 Suppl 5():S186-9. PubMed ID: 10614919
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, van der Gaag R.
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F, González-Ortiz M, Durón H, Sánchez C.
    Rev Invest Clin; 2002 May; 54(4):307-10. PubMed ID: 12415954
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The choices of therapy in Graves' disease.
    Stanbury JB.
    Med Times; 1970 Nov; 98(11):105-20. PubMed ID: 4097048
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical and morphologic comparisons in toxic goiter].
    Grigor'ev PIa, Samoteĭkin MA, Korolev RV.
    Arkh Patol; 1967 Nov; 29(6):55-8. PubMed ID: 4178179
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Graves' disease].
    Radetti G, Rigon F, Tatò L, Tonini G, Bernasconi S, Bona G, Bozzola M, Buzi F, de Santis C, De Sanctis V.
    Minerva Pediatr; 1997 Nov; 49(11):545-7. PubMed ID: 9549300
    [No Abstract] [Full Text] [Related]

  • 20. Concentration of TSH-receptor antibodies (TBII) in the sera of patients with immunogenic hyperthyroidism (Graves' disease) receiving antithyroid medication.
    Budihna N, Pavlin K, Porenta M.
    Radiobiol Radiother (Berl); 1987 Nov; 28(1):101-6. PubMed ID: 2438715
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.